Acute coronary syndrome (ACS) is a major cause of morbidity and mortality
|
|
- Randall Crawford
- 6 years ago
- Views:
Transcription
1 32 Journal of the association of physicians of india vol 62 published on 1st of every month 1st july, 2014 Original Article Novel Atherosclerotic Risk Factors and Angiographic Profile of Young Gujarati Patients with Acute Coronary Syndrome Jayesh Prajapati 1, Sharad Jain 1, Kapil Virpariya 1, Jayesh Rawal 1, Hasit Joshi 1, Kamal Sharma 1, Bhavesh Roy 1, Ashok Thakkar 2 Abstract Objectives : In this study we aimed to analyse the frequency of atherosclerotic risk factors with focus to novel risk factors for coronary artery disease and angiographic profile in young ( 40 years) acute coronary syndrome (ACS) patient with healthy controls in Gujarat, India. Methods : Between January 2008 and December 2012, 109 consecutive young patients aged 40 years old, diagnosed to have ACS were included in the study. All ACS patients underwent diagnostic coronary angiography. An equivalent age and sex matched population without coronary disease with similar risk factors without tobacco considered a control group. All angiographic patients were evaluated for conventional risk factors for coronary artery disease like diabetes mellitus, hypertension, smoking, obesity as well as novel atherogenic risk factors like high sensitivity C-reactive protein (Hs-CRP), Lipoprotein(a) [LP(a)], homocysteine, apolipoprotein A1 (ApoA1) and B (ApoB). Result : In a study group, out of 109 young patients, 90 (82.6%) patients were presented to our hospital as ST-segment elevation myocardial infarction (STEMI), 10 (9.2%) presented as known non- ST-elevation myocardial infarction (NSTEMI) and 9 (8.3%) presented as unstable angina (UA). Serum cholesterol, triglycerides, LDL, LP(a) and lipid tetrad index were significantly higher in the study group whereas the HDL levels significantly lower as compared to the control group. Conclusion : A quite common risk factors of premature CAD are smoking, high Hs-CRP, high LP(a), hyperhomocysteinaemia and positive family history in the young ACS. Most common presentation of ACS in young was STEMI. On angiography, single vessel involvement was the most common finding. 1 Department of Cardiology, U.N. Mehta Institute of Cardiology and Research Centre, Ahmedabad , Gujarat; 2 Department of Clinical Trials, Sahajanand Medical Tech. Pvt. Ltd., Surat , Gujarat Received: ; Revised: ; Accepted: Introduction Acute coronary syndrome (ACS) is a major cause of morbidity and mortality worldwide. 1 Worldwide, about 4% of patients presented with ACS are younger than 40 years of age. 2 The burden of ACS can be substantial if the individual is relatively young as they are commonly breadwinners of the family and in the prime of their working life with significant contributions to the society. Premature CAD disease is defined as occurring below the age of 40 years. Cardiovascular disease (CVD) is posing a major public health hazard and clinical problem in South Asia (India, Pakistan, Bangladesh, and Nepal). Estimates from the Global burden of Disease Study suggest that by the year 2020 this part of world will have more individuals with atherosclerotic CVD than any other region. 3 There is documented evidence that South Asian people develop CAD at a higher rate and also at an early age. 4 In India, 12% 16% of CAD patients are young. Half of the CVD related deaths (52% of CVDs) in India occur below the age of 50 years, and about 25% of acute myocardial 584 JAPI july 2014 VOL. 62
2 Journal of the association of physicians of india vol 62 published on 1st of every month 1st july, Table 1 : Baseline characteristics of the study and control groups Variables Study group infarction (AMI) in India occurs under the age of 40 years. 5 Indians have a 3-fold risk of developing AMI before age of 46 compared to Malays (1.25-fold risk) and Chinese (0.7-fold risk) respectively. 6 In general, myocardial infarction (MI) develops 5-10 years earlier in Asian Indians than in other populations, and its occurrence in patients under 40 is 5 to10-fold higher. Young ACS patients frequently have characteristics that are different from those seen in older patients. While conventional risk factors clearly play a major role in the predisposition to ACS, a significant number of young patients with ACS do not have any of the conventional risk factors. 7 There are few data available regarding novel atherosclerotic risk factors in patients with premature onset acute coronary syndrome in South Asia So this study was designed to analyse the frequency of different risk factors for coronary artery disease with focus on novel risk factors in young ( 40 years) population presented with ACS in Gujarat, India. Material and Methods Control group p-value Age in years (mean ± SD) 34.5 ± ± 6.0 NS Male, n (%) 98 (89.9%) 80 (73.4%) < Female, n (%) 11 (10.1%) 35 (32.1%) < BMI, kg/m 2 (mean ± SD) 25.6 ± ± 4.5 < Over weight, n (%) 40 (36.7%) 32 (29.4%) < Obese, n (%) 6 (5.5%) 8 (7.3%) NS Smoker, n (%) 21 (19.3%) - - Hypertension, n (%) 21 (19.3%) 20 (18.3%) NS Diabetes mellitus, n (%) 28 (25.7%) 4 (3.7%) < Family History of premature CAD, n (%) 19 (17.4%) 10 (9.2%) < Values are expressed as n (%) or mean ± SD Study Population This study was carried out in the Department of Cardiology, U.N. Mehta Institute of Cardiology and Research, from January 2008 to December This institute is tertiary care centre situated in Ahmedabad, Gujarat, India. A total number of 109 patients aged up to 40 years with clinical, biochemical and ECG features suggestive of ACS were included. The diagnosis of ACS is defined by at least one of the following: (1) Occurs at rest or minimal exertion and usually lasts > 20 minutes (if nitroglycerin is not administered) (2) Being severe and described as frank pain and of new onset (i.e., within 1 month) (3) Occurs with a crescendo pattern (more severe, prolonged, or increased frequency than previously). 13 An equivalent age and sex matched population without coronary disease with similar risk factors without tobacco considered a control group. The study protocol was approved by the institutional ethics committee and a signed; informed consent was obtained from every enrolled patient. Methods All patients were investigated for novel atherosclerotic risk markers like Hs-CRP, LP(a), homocysteine, ApoA1 and ApoB. Quantitative estimation of LP(a) was done by turbidometry. Total cholesterol, triglycerides (TG) and high density lipoproteins (HDL) were estimated by standard procedure; low density lipoproteins (LDL) Cholesterol levels were estimated using the Friedwald Formula. Lipid tetrad index 14 is calculated by the product of cholesterol, triglycerides and LP (a) values divided by the HDL level. [Total cholesterol x triglycerides x LP(a)/HDL] Patients with valvular heart disease, congenital heart disease, hypertrophic cardiomyopathy and coronary artery anomalies were excluded from the study. Statistical Analysis The collected data were tabulated and analysed by using the Statistical Package for Social Sciences (SPSS for Windows version 20.0; Chikago, IL, USA). Quantitative data were expressed as mean value ± SD. The independent student s t-test has been used to carry out significant changes quantitative data. Also, Chi-square and Fisher exact test have been used to carry out significant change in qualitative data. The p value < 0.05 consider as a statistically significant. Results The baseline characteristics of the study group () and the control group (n = 109) are shown in Table 1 and Figure 1. The two groups were matched with respect to the age and sex as control without coronary disease but similar risk factors without tobacco. The present study included 109 young patients ( 40 years) with ACS with age ranged from 30 to 40 years. Out of 109 young ACS patients 98 (89.9%) were male and 11 (10.1%) were female. As per modified Prasad classification 15 out of 109 patients, 72(66.1%) belonged to lower socioeconomic class, 45(41.3%) belonged to middle class and 5(4.6%) belonged to upper class. Table 2 and Figure 2 showed the clinical presentation and angiographic findings of studied patients. All patients were evaluated for conventional risk factors as well as novel atherogenic risk factors. The mean value of total cholesterol, LDL levels, HDL levels, TG levels and mean lipid tetrad index were ± 44.2 mg/dl, 95.1 ± 45.1 mg/dl, 36.5 ± 11.3 JAPI july 2014 VOL
3 34 Journal of the association of physicians of india vol 62 published on 1st of every month 1st july, 2014 Table 2 : Clinical presentation and angiographic findings of study group ( patients) Presentation Anterior STEMI, n (%) 61 (56.0%) Inferior STEMI, n (%) 29 (26.6%) NSTEMI, n (%) 10 (9.2%) Unstable Angina, n (%) 9 (8.3%) Coronary Angiographic Evaluation Single Vessel Disease, n (%) 57 (52.3%) Double Vessel Disease, n (%) 15 (13.8%) Triple Vessel Disease, n (%) 6 (5.5%) Recanalise Single Vessel, n (%) 23 (21.1%) Triple Vessel Disease with LMCA, n (%) 3 (2.8%) Normal Vessels, n (%) 5 (4.6%) Arteries involved LAD, n (%) 64 (58.7%) LCX, n (%) 20 (18.3%) RCA, n (%) 23 (21.1%) LM, n (%) 2 (1.8 %) mg/dl, ± 75.3 mg/dl and ± respectively, in study group as shown in Table 3. There were 45 (41.3%) patients had lipid tetrad index > 20,000. There was a significant difference in levels of TG, TC, HDL, LDL, LP(a), Hs-CRP and BMI (p < 0.05). but no remarkable difference in other factors between the CAD group and the control group (p >0.05) Discussion Tobacco smoking is an established conventional coronary risk factor for CAD. Casual association between tobacco chewing (smokeless tobacco) and CAD is found in some case control studies. 16 Tobacco increases the risk of cardiovascular disease by raising blood pressure, damaging vascular endothelium, increasing LDL-cholesterol oxidation, and lowers the HDL-cholesterol. On an average, mcg of nicotine is absorbed through lungs and oral mucosa with each puff of tobacco or about 1 to 2 mg per cigarette. 16 As per National Family Health Survey (NFHS-3) in Gujarat; prevalence of tobacco use by any form is 60.2% in men and 8.4% in women. 17 Tobacco consumption was found to be most common addiction in young ACS patients. It was found in 65.3% which is comparable to study done by Rohit V. Ram and Atul V. Trivedi in Gujarat. 16 In our study majority of patients were tobacco chewer rather than smoker. The excess burden of CAD among South Asians appears to be primarily due to dyslipidaemia that is characterised by: high levels of ApoB, triglycerides, Lipoprotein(a), Lipid tetrad index, borderline high levels of LDL (low-density lipoprotein) cholesterol, low levels of HDL (high-density lipoprotein) cholesterol and ApoA1. 17 Total cholesterol levels and LDL levels are Table 3 : Comparison of risk profile of study and control group Variables Study group mean ± SD Control group mean ± SD p-value Total Cholesterol (mg/dl) ± ± 42.8 < LDL (mg/dl) ± ± 45.1 < HDL (mg/dl) 36.5 ± ± 11.1 < Non HDL Cholesterol ± ± (mg/dl) Total Lipid (mg/dl) ± ± NS VLDL (mg/dl) 28.0 ± ± 14.7 NS Triglyceride (mg/dl) ± ± 73.6 < Lipoprotein (a) (mg/dl) 37.1 ± ± 5.2 < Homocysteine (µmol/l) 26.0 ± Hs-CRP (mg/l) 16.7 ± ± 4.38 < Ratio of TC & HDL (mg/ dl) 5.1 ± ± Lipid Tetrad Index ± ± < Mean Apo B/A1 ratio LDL: Low density lipoprotein; HDL: High density lipoprotein; NS: Not significant; VLDL: Very low density lipoprotein; TC: Total cholesterol correlated with extent and severity of CAD in Asian Indians as in whites. But at any given total cholesterol or LDL level, Asian Indians have a greater CAD risk than whites. Therefore; Asian Indians with dyslipidaemia should be treated as aggressively as if they had a CAD risk equivalent similar to the treatment of patients with diabetes or heart disease. Thus, while a total cholesterol level of < 200 mg/dl is desirable according to the Framingham model for those with 0 to 1 risk factor, the goal for the Asian Indian population should be < 160 mg/dl. An LDL level of < 160 mg/dl is appropriate for most Americans with 0 to 1 risk factor, but a level of < 100 mg/dl is optimal for Asian Indians. HDL levels of 60 mg/dl are considered optimal in both whites and Asian Indians. HDL levels are considered low when they drop below 40 mg/dl. However, most experts consider a level < 50 mg/dl to be low in women. The acceptable normal level of triglycerides was decreased from < 200 mg/ dl to < 150 mg/dl from the Adult Treatment Panel (ATP) II report to the ATP III classification. Lipoprotein (a) appears to be a major risk factor in Asian Indians as compared to whites. Elevated LP(a) found in 35-40% of all Indians High LP(a) levels are highly correlated with the severity of ACS, recurrent events, poor prognosis, and increased mortality. 18 A high level of LP(a) is shown to the most prevalent dislipidaemia in our young patients with premature CAD. LP(a) levels are governed almost exclusively by race, ethnicity, and genetics, unlike other lipids, where the levels are influenced by age, gender, diet, and other environmental factors. The effect of LP(a) on the atherogenicity is not additive but multiplicative 586 JAPI july 2014 VOL. 62
4 Journal of the association of physicians of india vol 62 published on 1st of every month 1st july, % 50.0% 40.0% 56.0% 40.0% 35.0% 30.0% 25.0% 36.7% 29.4% 25.7% Study group () Control group () 30.0% 26.6% 20.0% 19.3% 18.3% 17.4% 15.0% 20.0% 10.0% 9.2% 8.3% 10.0% 5.0% 3.7% 9.2% 5.5% 7.3% 0.0% Anterior STEMI Inferior STEMI NSTEMI Unstable Angina Fig. 1 : Baseline characteristics of the study and control groups which is well demonstrated by the lipid tetrad index. A high index (> 20,000) would indicate the presence of a highly atherogenic lipid profile and increase CV risk. Lipid tetrad index may be the best estimate of the total burden of dyslipidaemia as it eliminates the need for various cut-off points and ratios involving the lipid subsets. Although LP(a) levels > 30 mg/dl are generally considered the threshold at which high risk of premature CAD increases rapidly, levels below 20 mg/dl are considered optimum, particularly in Asian Indians. Modestly elevated LP(a) levels of 20 mg/dl to 30 mg/dl are associated with a 2- to 3-fold higher risk of ACS or restenosis following coronary angioplasty and bypass surgery. This risk increases 10-fold when an LP(a) level > 50 mg/dl occurs in persons with high cholesterol levels. In the present study 26 (21.5%) patients had very high level LP(a). In DVD and TVD patients, LP (a) level was significant difference (p < 0.05) compared to low risk SVD patients. Homocysteine levels are higher among Asian Indians than others. In India, most people adhere to a vegetarian diet and vegetarians have 3.0 times higher risk of hyperhomocysteinaemia compared to those who eat non-vegetarian. Homocysteine levels > 15 µmol/l are found in 75-84% of subjects in India. The prevalence of hyperhomocysteinaemia in our study is comparable to study conducted in younger subject by A.K. Puri et al. in India. 19 Strong evidence indicates that Hs-CRP is associated with CAD events. Moderate, consistent evidence suggests that adding Hs-CRP to risk prediction models among initially intermediate-risk persons improves risk stratification. However, sufficient evidence that reducing Hs-CRP levels prevent CAD events is lacking. 20 Mean Hs-CRP level in our study were 16.7 ± 22.7 mg/l which correlates with study done by Tenzin Nyandak et al. Delhi, India. 21 We have found very high Hs-CRP probably because of we have evaluated in ACS patients which was itself inflammatory condition. There is now compelling evidence that the ApoB/ ApoA1 ratio is a better index of the likelihood of 0.0% Over weight Fig. 2 : Clinical presentation with ACS () vascular events than any of the corresponding cholesterol indices: the total cholesterol/high-density lipoprotein cholesterol (HDL-C) ratio, non-hdl-c/ HDL-C ratio, or low-density lipoprotein cholesterol (LDL-C)/HDL-C ratio. ApoB/A-1 ratio > 1 associated with increased CV risk. Relation between risk and ApoB is continuous, whereas at the extremes of HDL concentration in plasma the relation to risk is not certain. Appreciating these distinctions should allow appropriate use of the ApoB/ApoA1 ratio as a simple, single, summary index of the lipoprotein-related risk of vascular disease. 22 In our study mean Apo B/A1 ratio is only This could because of most of our patients have very low HDL. In our study ratio of TC and HDL was 5.1 ± 3.3 in the study group and 3.9 ± 1.4 in the control group. Our study correlates with study done by Daulat Manurung. 23 Conclusions A quite common risk factors of premature CAD are smoking, high Hs-CRP, high LP(a), hyperhomocysteinaemia and positive family history in the young ACS. Most common presentation of ACS in young was STEMI. On angiography, single vessel involvement was the most common finding. References Diabetes mellitus 1. Ridker MP, Genest J, Libby P.Risk factors for atherosclerotic disease. Braunwald E, Zipes DP, Libby P, editors. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia: W.B Saunders Company 2001: Lamm G. The epidemiology and acute myocardial infarction in young age groups. In: Roskamm H, ed. Myocardial Infarction at Young Age. Berlin: Springer-Verlag. 1981: Yusuf S, Ounpuu S. Tackling the growing epidemic of cardiovascular disease in South Asia. J Am Coll Cardiol 2001;38: Chakraborty B, Zaman F, Sharma AK. Combating coronary artery disease in South Asia- What is special? Bangladesh J Cardiol 2009;1: Sharma M, Ganguly NK. Premature coronary artery disease in Indians Hypertension Family History of CAD Obese JAPI july 2014 VOL
5 36 Journal of the association of physicians of india vol 62 published on 1st of every month 1st july, 2014 and its associated risk factors. Vasc Health Risk Manag 2005;1: Wong CP, Loh SY, Loh KK, Ong PJ, Foo D, Ho HH. Acute myocardial infarction: Clinical features and outcomes in young adults in Singapore. World J Cardiol 2012;4: Seedat YK, Mayet FG, Khan S, Somers SR, Joubert G. Risk factors for coronary heart disease in the Indians of Durban. S Afr Med J 1990;78: Tambyah PA, Lim YT, Choo MH. Premature myocardial infarction in Singapore--risk factor analysis and clinical features. Singapore Med J 1996;37: Chan MY, Woo KS, Wong HB, Chia BL, Sutandar A, Tan HC. Antecedent risk factors and their control in young patients with a first myocardial infarction. Singapore Med J 2006;47: Ismail J, Jafar TH, Jafary FH, White F, Faruqui AM, Chaturvedi N. Risk factors for non-fatal myocardial infarction in young South Asian adults. Heart 2004;90: Enas EA, Yusuf S, Sharma S. Coronary artery disease in South Asians. Second meeting of the International Working Group. 16 March 1997, Anaheim, California. Indian Heart J 1998;50: Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996;48: Christopher P. Cannon and Eugene Braunwald. Unstable Angina and Non ST Elevation Myocardial Infarction. In: Braunwald s Heart Disease - A Textbook of Cardiovascular Medicine, 9th ed. Saunders, 2011: Singh Y, Srivastava S, Ahmad S, Mishra S, Shirazi N, Raja M, Verma S. Is Lipid Tetrad Index the Strongest Predictor of Premature Coronary Artery Disease in North India? JIACM 2010;11: Agarwal A. Social classification: the need to update in the present scenario. Indian J Community Med 2008;33: Ram RV, Trivedi AV. Behavioral risk factors of coronary artery disease: A paired matched case control study. J Cardiovasc Dis Res 2012;3: International Institute for Population Sciences. National family health survey (NFHS)-3, : 18. Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010;31: Puri A, Gupta OK, Dwivedi RN, Bharadwaj RP, Narain VS, Singh S. Homocysteine and lipid levels in young patients with coronary artery disease. J Assoc Physicians India 2003;51: Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151: Nyandak T, Gogna A, Bansal S, Deb M. High sensi-tive C-reactive protein (hs-crp) and its correlation with angiographic severity of coronary artery disease. JIACM 2007;8: Sniderman AD, Kiss RS. The strengths and limitations of the apob/ apoa-i ratio to predict the risk of vascular disease: a Hegelian analysis. Curr Atheroscler Rep 2007;9: Manurung D. Lipid profiles of acute coronary syndrome patients hospitalized in ICCU of Cipto Mangunkusumo Hospital. Acta Med Indones 2006;38: JAPI july 2014 VOL. 62
PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
Pak Heart J ORIGINAL ARTICLE PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Burhan Akhtar, Nauman Ali, Rana Kashif - Department Of Cardiology,
More informationOriginal Article. Gautam A.G 1, Bansal P 2, Chauhan R 3, Chadha V 4 NTRODUCTION
Original Article A Prospective Study To Know Socio-Demographic Profile In Patients With Acute Coronary Syndrome Admitted At A Tertiary Health Care And Teaching Hospital In Himachal Pradesh, North India
More informationDemographic profile and prevalence of risk factors and their correlation with STEMI, NSTEMI and premature CAD in documented CAD patients
Demographic profile and prevalence of risk factors and their correlation with STEMI, NSTEMI and premature CAD in documented CAD patients 1 3 Sharad Gupta, DM, Vitull K. Gupta, MD, Rupika Gupta, MD, Sonia
More informationCARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION
ORIGINAL ARTICLE CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION Sibasis Sahoo 1, Komal Shah 2,Anand Shukla 3, Jayesh Prajapati 3, Pratik
More informationPrevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery
Original Article Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery RR Kasliwal*, A Kulshreshtha**, Sweta Agrawal**, M Bansal***, N Trehan+ Abstract
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationAssessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution
CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationJUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study
Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary
More informationMetabolic Syndrome in Female Patients with Ischaemic Heart Disease: A prospective study
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/470 Metabolic Syndrome in Female Patients with Ischaemic Heart Disease: A prospective study Ex. Maj. S K Gupta Graded
More informationBehavioral risk factors of coronary artery disease: A paired matched case control study
JCDR Original Article Behavioral risk factors of coronary artery disease: A paired matched case control study Rohit V. Ram, Atul V. Trivedi 1 Community Medicine Department, M. P. Shah Medical College,
More informationDECLARATION OF CONFLICT OF INTEREST. None
DECLARATION OF CONFLICT OF INTEREST None BURDEN OF CORONARY ARTERY DISEASE IN DIABETES IN INDIA Amal Kumar Banerjee MD, DM,FACC,FESC,FACP,FAPSC,FICC President Association of Physicians of India SAARC Cardiac
More informationIn-Ho Chae. Seoul National University College of Medicine
The Earlier, The Better: Quantum Progress in ACS In-Ho Chae Seoul National University College of Medicine Quantum Leap in Statin Landmark Trials in ACS patients Randomized Controlled Studies of Lipid-Lowering
More informationLIPOPROTIEN APHERESIS. Bruce Sachais, MD, PhD Executive Medical Director New York Blood Center
LIPOPROTIEN APHERESIS Bruce Sachais, MD, PhD Executive Medical Director New York Blood Center OUTLINE Familial Hypercholesterolemia (FH) Diagnosis Treatment options Lipoprotein apheresis Procedures Expected
More informationIndian Journal of Basic & Applied Medical Research; December 2011: Issue-1, Vol.-1, P
Comprehensive levels of Serum Enzymes and Lipid Profile testing in MI and Stable Angina Subjects. K.Satya Narayana*, Dr.Anija Uchuru**, Dr.Ivvala Anand Shaker*, S.Saleem Basha*, K.Suresh Babu* *Dept of
More informationPOST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015
No. of Printed Pages : 20 MCC-006 POST GRADUATE DIPLOMA IN CLINICAL 0 CARDIOLOGY (PGDCC) Term-End Examination June, 2015 MCC-006 : CARDIO VASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note :
More informationLipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures
Lipoprotein (a): Should We Measure? Should We Treat? Joseph P. McConnell, Ph.D. DABCC Health Diagnostic Laboratory Inc. Baptist Health South Florida Eleventh Annual Cardiovascular Disease Prevention International
More informationLow-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies
Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society
More informationAssociation of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis
Original Article Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis V Achari, AK Thakur Abstract Background : The relative importance of
More informationPrediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal
Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Koju R, Gurung R, Pant P, Humagain S, Yogol CM, Koju A, Manandhar K, Karmacharya B, Bedi TRS Address for Correspondence:
More informationORIGINAL ARTICLE Blood Lipid Profile in Acute Coronary Syndrome and Chronic Stable Angina Patients ABSTRACT
ORIGINAL ARTICLE Blood Lipid Profile in Acute Coronary Syndrome and Chronic Stable Angina Patients T Parvin 1, MH Rahman 2, S Ferdousi 2, A Shahnaz 2, M Mahal 2 SF Ahmed 1, BA Ferdous 3, DAS Hussain 4
More informationVascular Inflammation and Angiographic Severity of Coronary Artery Disease in Young Asian Indians
Original Article JCDR Vascular Inflammation and Angiographic Severity of Coronary Artery Disease in Young Asian Indians Imran Ahmed **, Achyut Sarkar *, Arindam Pande **, Naveen Chandra GS **, Shailesh
More informationDyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram
Dyslipidaemia Is there any new information? Dr. A.R.M. Saifuddin Ekram PhD,FACP,FCPS(Medicine) Professor(c.c.) & Head Department of Medicine Rajshahi Medical College Rajshahi-6000 New features of ATP III
More informationLife Science Journal 2018;15(12)
Multicenter observational study of risk factors profile in a sample of Egyptian Patients with Acute Coronary Syndrome (part of Egyptian Cardiovascular Risk Factors Project) Prof. Dr. Ahmed Ashraf Reda,
More informationMethods. OR and PAR both presented with 99% confidence intervals. All analyses adjusted for age, sex and region.
INTERHEART: Aims 1. To evaluate the association (odds ratio) of risk factors for MI globally, and in each region; and among major ethnic groups in the world. 2. To quantify the impact of each risk factor
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationLipoprotein (a): Is it important for Friedewald formula?
ORIGINAL RESEARCH ALBANIAN MEDICAL JOURNAL Lipoprotein (a): Is it important for Friedewald formula? Murat Can 1, Berrak Guven 1 1 Bulent Ecevit University, Faculty of Medicine, Department of Biochemistry
More informationSupplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
More informationCase Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer
Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationStudy of pattern of acute myocardial infarction in tertiary care hospital of Ahmedabad, Gujarat
Original Research Article Study of pattern of acute myocardial infarction in tertiary care hospital of Ahmedabad, Gujarat Sangita Rathod 1*, Ashish Parikh 2 1 Assistant Professor, Department of Medicine,
More informationEarly cardiovascular risk factors in South Asians
Early cardiovascular risk factors in South Asians MINTU TURAKHIA, MD MAS Instructor of Medicine, Stanford University Director of Cardiac Electrophysiology, Palo Alto VA Research Chair, South Asian Heart
More informationDivision of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan
Association between continuously elevated C-reactive protein and restenosis after percutaneous coronary intervention using drug-eluting stent in angina patients Division of Cardiovascular Medicine, Jichi
More informationTerm-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple
More informationPrognostic values of high-sensitivity C-reactive protein for patients receiving percutaneous coronary intervention.
Biomedical Research 2017; 28 (4): 1906-1910 ISSN 0970-938X www.biomedres.info Prognostic values of high-sensitivity C-reactive protein for patients receiving percutaneous coronary intervention. Zheng Tan
More informationWhich CVS risk reduction strategy fits better to carotid US findings?
Which CVS risk reduction strategy fits better to carotid US findings? Dougalis A, Soulaidopoulos S, Cholongitas E, Chalevas P, Vettas Ch, Doumtsis P, Vaitsi K, Diavasti M, Mandala E, Garyfallos A 4th Department
More informationTitle for Paragraph Format Slide
Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38
More informationThe New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk
The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing
More informationSafety of Anacetrapib in Patients with or
Safety of Anacetrapib in Patients with or at Risk for Coronary Heart Disease Christopher P. Cannon, MD, Sukrut Shah, PhD, RPh, Hayes M. Dansky, MD, Michael Davidson, MD, Eliot A. Brinton, MD, Antonio M.
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationConceptual Approach to CAD Risk. Disclosures. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management 2/10/2014.
Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management None Disclosures Arthur Agatston Conceptual Approach to CAD Risk Devereux Circulation, 1993 1 Age Obesity Family Hx Diabetes
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationThe JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009
The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain
More informationLipoprotein Particle Profile
Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular
More informationCOMPARISON OF APOLIPOPROTEIN CONCENTRATIONS AND VALUES OF APOB:APOAI
COMPARISON OF APOLIPOPROTEIN CONCENTRATIONS AND VALUES OF APOB:APOAI WITH TRADITIONAL LIPID MEASURES IN WOMEN DIAGNOSED WITH ACUTE CORNONARY SYNDROMES A PRELIMINARY REPORT. Magdalena Krintus, Katarzyna
More informationCase Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA
Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after
More informationBMR Medicine. Research Article
www.bmrjournals.com Open Access Scientific Publisher Research Article RELATIONSHIP BETWEEN WHITE BLOOD CELL (WBC) COUNT AND C-REACTIVE PROTEIN (CRP) WITH ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE
More informationComparison of Lipoprotein (a) and Apolipoproteins in Children with and without Familial History of Premature Coronary Artery Disease
Short Comunication Iran J Pediatr Jun 2008; Vol 18 ( No 2), Pp:159-162 Comparison of Lipoprotein (a) and Apolipoproteins in Children with and without Familial History of Premature Coronary Artery Disease
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationDISTRIBUTION AND DETERMINANTS OF CORONARY ARTERY DISEASE
DISTRIBUTION AND DETERMINANTS OF CORONARY ARTERY DISEASE IN AN URBAN PAKISTANI SETTING Objective: We assessed the distribution of coronary artery disease (CAD) and its association with the major biological
More informationIt is currently estimated that diabetes prevalence by
clinical Study The Prevalence and Pattern of Dyslipidemia among Type 2 Diabetic Patients at Rural Based Hospital in Gujarat, India Hetal Pandya*, JD Lakhani**, J Dadhania, A Trivedi Abstract Only proper
More information4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for
+ Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics
More informationLatest Guidelines for Lipid Management
Latest Guidelines for Lipid Management Goals Recognize the differences between different guidelines Understand the effective strategies to tailor lipid lowering therapies based on evidence and guideline
More information10/17/16. Assessing cardiovascular risk through use of inflammation testing
Assessing cardiovascular risk through use of inflammation testing Anthony L. Lyssy, DO Medical Director and Managing Partner Diamond Physicians Dallas, TX Response to Injury Hypothesis Injury Response
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationDemographic and clinic-angiographic profile of coronary artery disease in young adults: a retrospective observational study
International Journal of Research in Medical Sciences Swain L et al. Int J Res Med Sci. 2018 Jul;6(7):2264-2270 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20182428
More informationHigh Sensitive C-Reactive Protein (hs-crp) and its Correlation with Angiographic Severity of Coronary Artery Disease (CAD)
ORIGINAL ARTICLE JIACM 2007; 8(3): 217-21 High Sensitive C-Reactive Protein (hs-crp) and its Correlation with Angiographic Severity of Coronary Artery Disease (CAD) Tenzin Nyandak*, Arun Gogna**, Sandeep
More informationTracking a Killer Molecule
Tracking a Killer Molecule Mercodia Oxidized LDL ELISA www.mercodia.com Mercodia Oxidized LDL ELISA products Product Catalog No Kit size Oxidized LDL ELISA 10-1143-01 96 wells Oxidized LDL competitive
More informationFrequency of Dyslipidemia and IHD in IGT Patients
Frequency of Dyslipidemia and IHD in IGT Patients *Islam MS, 1 Hossain MZ, 2 Talukder SK, 3 Elahi MM, 4 Mondal RN 5 Impaired glucose tolerance (IGT) is often associated with macrovascular complications.
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationEXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION
1 A STUDY ON THE EFFECT OF DIET & LIFE STYLE ON THE INCIDENCE OF CORONARY ARTERY DISEASE IN MODERATELY DRINKING EX MILITARY MEN IN PATHANAMTHITTA DISTRICT. EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT
More informationLow-density lipoprotein as the key factor in atherogenesis too high, too long, or both
Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both Lluís Masana Vascular Medicine and Metabolism Unit. Sant Joan University Hospital. IISPV. CIBERDEM Rovira i Virgili
More informationChanging lipid-lowering guidelines: whom to treat and how low to go
European Heart Journal Supplements (2005) 7 (Supplement A), A12 A19 doi:10.1093/eurheartj/sui003 Changing lipid-lowering guidelines: whom to treat and how low to go C.M. Ballantyne Section of Atherosclerosis,
More informationJMSCR Vol 06 Issue 11 Page November 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i11.44 Level of C-Reactive Protein
More informationAnkle Brachial Index as a Predictor of Coronary Artery Disease in Diabetic Patients
Original Research Article Ankle Brachial Index as a Predictor of Coronary Artery Disease in Diabetic Patients Sangeeta Pednekar 1*, Nishita Singh 2, Elizabeth James 3, Dharmendra Pandey 2 1 Professor,
More informationAppendix 1. Data shown in Table 1
Age Mean BMI Source Group Status Region Country Population (years) Male Female Source Number Five Cities 25-64 22.7 Settibalija >20 19.87 19.53 South Andhra Pradesh 18-75 21.41 22.34 Wadabalija >20 20.09
More informationORIGINAL ARTICLE. APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population
22 Journal of The Association of Physicians of India Vol. 65 October 2017 ORIGINAL ARTICLE APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population Ranjan Modi
More informationThe investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India
eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationClinical Study of Lipid Profile Pattern in Acute Coronary Syndromes
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/359 Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes V Suresh Kumar, Madavaram Sreelatha Assistant
More informationRisk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium
Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from
More informationDyslipidemia in the light of Current Guidelines - Do we change our Practice?
Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationBeyond LDL-Cholesterol
Biomarkers for Risk Stratification Beyond LDL-Cholesterol Athanasios J.Manolis Director Cardioilogy Dep, Asklepeion Hospital, Athens, Greece Adj. Professor of Medicine, Emory University Atlanta, USA Adj.
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationC-Reactive Protein and Your Heart
C-Reactive Protein and Your Heart By: James L. Holly, MD Inflammation is the process by which the body responds to injury. Laboratory evidence and findings at autopsy studies suggest that the inflammatory
More informationSoo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital
Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital 1. Importance of Lowering LDL-Cholesterol in Diabetes Patients & Lipid Guidelines Prevalence of dyslipidemia in Korea Prevalence
More informationFREQUENCY OF CONVENTIONAL RISK FACTORS AMONG CORONORY ARTERY DISEASE PATIENTS IN TRIBAL AREA OF PAKISTAN
ORIGINAL ARTICLE Pak Heart J FREQUENCY OF CONVENTIONAL RISK FACTORS AMONG CORONORY ARTERY DISEASE PATIENTS IN TRIBAL AREA OF PAKISTAN 1 3 4 Muhammad Asif Iqbal, Ikramullah, Abdul Hadi, Muhammad Farooq,
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationBehind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL
Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationATP IV: Predicting Guideline Updates
Disclosures ATP IV: Predicting Guideline Updates Daniel M. Riche, Pharm.D., BCPS, CDE Speaker s Bureau Merck Janssen Boehringer-Ingelheim Learning Objectives Describe at least two evidence-based recommendations
More informationDavid Y. Gaitonde, MD, FACP Endocrinology DDEAMC, Fort Gordon
David Y. Gaitonde, MD, FACP Endocrinology DDEAMC, Fort Gordon I have no actual or potential conflicts of interest in relation to this program or presentation. Raphael School of Athens, 1509-1511 Apply
More informationDYSLIPIDEMIA RECOMMENDATIONS
DYSLIPIDEMIA RECOMMENDATIONS Α. DIAGNOSIS Recommendation 1 INITIAL LIPID PROFILING (Level of evidence II) It is recommended to GPs and other PHC Physicians to assess the lipid profile {total cholesterol
More informationMeasurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Original Policy Date
MP 2.04.22 Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with
More informationLipoprotein Subclassification Testing for Screening, Evaluation and Monitoring of Cardiovascular Disease
for Screening, Evaluation and Monitoring of Cardiovascular Disease Last Review Date: June 9, 2017 Number: MG.MM.LA.40Cv2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationBeyond Framingham: Risk Assessment & Treatment for Primary Prevention
Beyond Framingham: Risk Assessment & Treatment for Primary Prevention Ronald M. Goldenberg, MD, FRCPC, FACE Consultant Endocrinologist, North York General Hospital Medical Co-Director, LMC Endocrinology
More information2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center
2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular
More informationDyslipidemia and the Use of Statins. Troy L Randle, DO, FACC, FACOI
Dyslipidemia and the Use of Statins Troy L Randle, DO, FACC, FACOI Objective: Identify CV risk. Determine what dyslipidemia (dyslipoproteinemia) is Decrease CV risk and optimize lipid levels for your
More informationInflammation and and Heart Heart Disease in Women Inflammation and Heart Disease
Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular
More information2013 Cholesterol Guidelines. Anna Broz MSN, RN, CNP, AACC Cer=fied Adult Nurse Prac==oner North Ohio Heart, Inc.
2013 Cholesterol Guidelines Anna Broz MSN, RN, CNP, AACC Cer=fied Adult Nurse Prac==oner North Ohio Heart, Inc. Disclosures Speaker Gilead Sciences NHLBI Charge to the Expert Panel Evaluate higher quality
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 6 October 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 6 October 2010 CRESTOR 5 mg, film-coated tablet B/30 (CIP code: 369 853-8) B/90 (CIP code: 391 690-0) CRESTOR 10 mg,
More informationGender-Based and Age-Related Peculiarities of Lipid Metabolism in Chronic Heart Failure Secondary to Overweight and Obesity
71 P.P.Bidzilya Gender-Based and Age-Related Peculiarities of Lipid Metabolism in Chronic Heart Failure Secondary to Overweight and Obesity Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationImpact of metabolic syndrome on hospital in acute myocardial infarction patients
Original Article Impact of metabolic syndrome on hospital in acute myocardial infarction patients Pravin Rohidasrao Bhagat 1*, Shubhangi Virbhadra Swami 2 outcomes { 1 Assistant Professor, Department of
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationEvaluation of hs-crp levels in acute coronary syndromes
Original Research Article Evaluation of hs-crp levels in acute coronary syndromes R. S. Pushpa Kumari 1*, Priya John 2, V. A. Vipula 3 1 Professor, Department of General Medicine, MNR Medical College and
More information